Search Results 391-400 of 17120 for pharmacogenetics

1. Open-Label Extension Study of Setmelanotide - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

2. Jonathan B. Hoyne, Ph.D. - Mayo Clinic Faculty Profiles

   Mayo Clinic researcher Jonathan B. Hoyne, Ph.D., develops new laboratory tests for cancer, endocrine, autoimmune and neurological disorders.

3. A Study of an Implantable System for Remodulin Post Approval - Mayo Clinic

   Inclusion Criteria: Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements ...

4. Faculty - Department of Molecular Pharmacology and Experimental Therapeutics Research - Mayo Clinic Research

   Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...

5. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   This is a study where a new drug, called GSK4771261 is being tested. Neither the study doctors, study staff or participants will be aware of what treatment is ...

6. Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia - Mayo Clinic

   Dasatinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy work in different ways to stop ...

7. Medical Research & Education - Mayo Clinic News Network

   As scientists at the Mayo Clinic Center for Individualized Medicine discover new ways to use genomic information in the diagnosis, treatment and prevention of ...

8. Jonathan B. Hoyne - Mayo Clinic Faculty Profiles

   Mayo Clinic researcher Jonathan B. Hoyne, Ph.D., develops new laboratory tests for cancer, endocrine, autoimmune and neurological disorders.

9. Monoclonal gammopathy of undetermined significance (MGUS) - Doctors and departments - Mayo Clinic

   A condition of blood plasma that produces altered antibodies that increase the risk of blood cancers and other conditions.

10. Transplant Organ Genomics to Help Prevent Rejection in Kidney Transplant Recipients – RNA-seq Signature Validation - Mayo Clinic

    About this study. The purpose of this study is to validate the use of an RNA-seq based peripheral blood assay in renal transplant recipients in adult kidney ...